WHO – Page 14 – Communicable Diseases Research

Influence of exercise and vitamin D on the immune system against Covid-19: an integrative review of current literature

Covid-19에 대한 면역 체계에 대한 운동과 비타민 D의 영향: 현재 문헌의 통합 검토

Review

Published on 2022-06-012022-09-11
Journal: Molecular and cellular biochemistry [Category] COVID19(2023년), SARS, 유전자 메커니즘,

Artesunate, imatinib, and infliximab in COVID-19: A rapid review and meta-analysis of current evidence

COVID-19의 Artesunate, imatinib 및 infliximab: 현재 증거에 대한 신속한 검토 및 메타 분석

Review

Published on 2022-06-012022-09-12
Journal: Immunity, Inflammation and Disease [Category] COVID19(2023년), SARS, 진단,

Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis

Article

Published on 2022-05-302022-10-06
Journal: Front Med (Lausanne) [Category] 진단,

Inhaled nitric oxide as temporary respiratory stabilization in patients with COVID-19 related respiratory failure (INOCOV): Study protocol for a randomized controlled trial

COVID-19 관련 호흡 부전(INOCOV) 환자의 일시적인 호흡 안정화로서 흡입된 산화질소: 무작위 대조 시험을 위한 연구 프로토콜

Article

Published on 2022-05-272022-09-11
Journal: PLoS ONE [Category] 임상,

[키워드] Acute respiratory failure adjunct airway anaesthesia blinded Blood cause of death COVID-19 death deoxygenated described End-Expiratory Pressure EudraCT fraction global public health High-flow oxygen Hypoxemia hypoxia Inhaled initial intubation life-threatening lung Lungs management margin measure mechanical ventilation nitric oxide no difference null hypothesis oxygen oxygen saturation pandemic Patient patients with COVID-19 PEEP pharmacological Positive end-expiratory pressure predominant preoxygenation primary outcome measure protocol Randomized Randomized controlled trial reduce Respiratory failure safety margin sequence severe hypoxia Shunt SpO2 Standard of care Trial Two-arm Ventilation WHO
[DOI] 10.1371/journal.pone.0268822 PMC 바로가기 [Article Type] Article

Evaluating the performance characteristics of five lateral flow assays for the detection of the SARS-CoV-2 nucleocapsid antigen

SARS-CoV-2 뉴클레오캡시드 항원 검출을 위한 5가지 측면 유동 분석의 성능 특성 평가

Article

Published on 2022-05-252022-09-11
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료법,

[키워드] 95% CI Accuracy acquisition age assays caution Chain Reaction Characteristics China collected Community complement complementary costly COVID-19 COVID-19 negative COVID-19 pandemic diagnostic Diagnostic accuracy early diagnosis ENCODE Evaluating facilitate female FIVE hospitalised individuals with COVID-19 Infection Inpatient Italy lateral flow MHRA nucleocapsid antigen outcomes Oxygenation Participants Patient patients with COVID-19 PCR testing performed polymerase chain polymerase chain reaction protocol ranged reverse-transcriptase polymerase chain reaction Rome RT-PCR RT-PCR assay RT-PCR assays RT-PCR testing SARS-CoV-2 SARS-CoV-2 antigen sensitivity swabbing the SARS-CoV-2 thresholds variable Variation was performed WHO
[DOI] 10.1038/s41598-022-12805-1 PMC 바로가기 [Article Type] Article

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

코로나19 입원 환자를 위한 렘데시비르 및 기타 3가지 약물: WHO 연대 무작위 시험의 최종 결과 및 업데이트된 메타 분석

Meta-Analysis

Published on 2022-05-212022-09-11
Journal: Lancet (London, England) [Category] 신약개발, 임상, 치료제,

[키워드] 1:1 allocation Analysis antiviral drugs assigned average both groups Characteristics Compliance controls country COVID-19 COVID-19 diagnosis database death died discharge discharged disease severity drug drugs eligible patient Endpoint enrolled exclusion Final futility hospital Hospital mortality hospitalised hospitalised patient Hospitalised patients Hydroxychloroquine in both groups in-hospital mortality Inpatient Inpatients interferon ISRCTN Kaplan-Meier Local Lopinavir meta-analyses Meta-analysis Mortality mortality analysis mortality rate ratio no significant effect occurred Open-label outcome oxygen participant Patient patients patients with COVID-19 Placebo placebos primary endpoint progressed progression proportion randomisation Randomised trial Randomly rate ratio receive recruited regions Registered Remdesivir reported secondary Secondary endpoints solidarity Solidarity trial Standard of care study drug the WHO treatment period Trial Ventilated Ventilation were given WHO
[DOI] 10.1016/S0140-6736(22)00519-0 PMC 바로가기 [Article Type] Meta-Analysis

Role of COVID-19 Vaccines in SARS-CoV-2 Variants

SARS-CoV-2 변이체에서 COVID-19 백신의 역할

Review

Published on 2022-05-202022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종,

Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis

활동성 결핵 진단 테스트 개발을 위한 전 용해 말초 혈액에서 ELISA에 의한 숙주 단백질 바이오마커 평가

Article

Published on 2022-05-202022-09-11
Journal: Frontiers in Immunology [Category] 바이오마커,

[키워드] analyses assay associative barrier Biomarker Biomarkers blood sample CALCOCO2 capture cause of death caused CD274 CD52 collected combinations complex conducted confirmatory tests consequence Control correlation country COVID-19 pandemic death defined development diagnosing Diagnosis diagnostic diagnostic test differentially expressed disease Diversity downregulated ELISA ENhance eradication evaluate expression GBP1 group groups Health Health crisis IFIT3 IFITM3 improvement Improvements incidence India individuals infected individuals Infection Infectious disease information investigated Key priorities key priority Laboratory Lateral flow device lysed negative controls nine Patient peripheral profile Protein protein expression Protein target protein targets qPCR Rapid reducing required ROC SAMD9L significantly SNX10 Stratification Test the WHO Tuberculosis validation study WHO World Health Organisation
[DOI] 10.3389/fimmu.2022.854327 PMC 바로가기 [Article Type] Article

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

독일에서 HIV에 감염된 남성과 성관계를 가진 남성의 HCV 미세 제거 모니터링을 위한 프레임워크 구축: 모델링 분석

Article

Published on 2022-05-122022-09-11
Journal: PLoS ONE [Category] 치료제,

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!

SARS-CoV-2 오미크론(B.1.1.529) 변형: 기다릴 시간이 없습니다!

Article

Published on 2022-05-112022-09-11
Journal: Acta bio-medica : Atenei Parmensis [Category] COVID19(2023년), SARS, 변종,